Global Cord Blood (NYSE:CO) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO) in a report released on Friday morning. The brokerage issued a strong-buy rating on the medical research company’s stock.

Global Cord Blood Trading Up 34.7 %

Shares of CO stock opened at $2.99 on Friday. The stock’s 50-day moving average price is $1.52 and its 200-day moving average price is $1.40. Global Cord Blood has a 12-month low of $2.03 and a 12-month high of $5.50. The stock has a market capitalization of $363.44 million, a price-to-earnings ratio of 1.95 and a beta of 0.16.

About Global Cord Blood

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.